Summit Financial’s Alpha Tau Medical DRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding DRTS
AF
AC
AIM
DSC
GIA
LCS
Summit Financial's DRTS Position: Q1 2026 in Review
Summit Financial reduced its Alpha Tau Medical (DRTS) stake by 32% in Q1 2026, selling an estimated $99.2K and leaving 30,000 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1325.
Summit Financial first reported a position in DRTS in Q3 2025 and has held it in 3 quarters since. The position peaked at $233K in Q3 2025. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.
- Summit Financial held 30,000 shares of Alpha Tau Medical worth $212K as of Q1 2026.
- Summit Financial sold 14,046 Alpha Tau Medical shares in Q1 2026, an estimated $99.2K.
- Alpha Tau Medical made up ﹤0.01% of Summit Financial's portfolio in Q1 2026, its #1325 holding.
- Summit Financial first reported a position in Alpha Tau Medical in Q3 2025 and has held it in 3 quarters since.
- Summit Financial's Alpha Tau Medical position peaked at $233K in Q3 2025.
- 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.
Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.